This file is part of IDEAS, which uses RePEc data


[ Papers | Articles | Software | Books | Chapters | Authors | Institutions | JEL Classification | NEP reports | Search | New papers by email | Author registration | Rankings | Volunteers | FAQ | Blog | Help! ]

Biotechnology business in Norway: Peripheral advantage, or just periphery?

Author info | Abstract | Publisher info | Download info | Related research | Statistics
Author Info
Terje Grønning (Department of educational research, University of Oslo)
Abstract

Research on biotechnology related firms has long been associated with the agglomeration of “dedicated biotechnology firms” and partners such as large corporations, research institutes and venture capital firms. At the same time it is acknowledged that such agglomeration trends may be most closely associated with medical biotechnology. This paper shows that there are more than 130 firms which may be classified as biotechnology related firms in Norway. Furthermore they are spread out throughout the country, albeit with more than half being located in the Eastern part. While there is indeed a great preoccupation with medical biotechnology also in Norway, the survey shows that two other distinct traits are present: a concentration of firms being focused on diagnostics and drug delivery rather than on therapeutics, and a focus on marine biotechnology (more than one third of the firms) within nutrition related products rather than or in addition to medical products. In addition to contributing these descriptive findings the paper thus opens up the agglomeration discussion, and suggests that foci on such niches as those which are prevalent in Norway may function with geographical distribution patterns different from those prevalent within the current medical biotechnology focused literature.

Download Info
To download:

If you experience problems downloading a file, check if you have the proper application to view it first. Information about this may be contained in the File-Format links below. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL: http://www.tik.uio.no/InnoWP/Final_Bio_7%20WPready.pdf
File Format: application/pdf
File Function:
Download Restriction: no

Publisher Info
Paper provided by Centre for Technology, Innovation and Culture, University of Oslo in its series Working Papers on Innovation Studies with number 20070607.

Download reference. The following formats are available: HTML (with abstract), plain text (with abstract), BibTeX, RIS (EndNote, RefMan, ProCite), ReDIF
Length: 42 pages
Date of creation: Aug 2007
Date of revision:
Handle: RePEc:tik:inowpp:20070607

Contact details of provider:
Postal: Postboks 1108 Blindern N-0317 Oslo
Phone: 22 84 16 00
Fax: : 22 84 16 01
Email:
Web page: http://www.tik.uio.no/Innovation
More information through EDIRC

For technical questions regarding this item, or to correct its listing, contact: (Koson Sapprasert).

Related research
Keywords:

Other versions of this item:

This paper has been announced in the following NEP Reports: This item is featured on the following reading lists:
  1. Technology Assessment
References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
  1. Gunnar Eliasson, 2000. "Industrial policy, competence blocs and the role of science in economic development," Journal of Evolutionary Economics, Springer, vol. 10(1), pages 217-241. [Downloadable!] (restricted)
  2. Susan Bartholomew, 1997. "National Systems of Biotechnology Innovation: Complex Interdependence in the Global System," Journal of International Business Studies, Palgrave Macmillan Journals, vol. 28(2), pages 241-266, June. [Downloadable!] (restricted)
  3. Goldfarb, Brent & Henrekson, Magnus & Rosenberg, Nathan, 2001. "Demand vs. Supply Driven Innovations: US and Swedish Experiences in Academic Entrepreneurship," Working Paper Series in Economics and Finance 0436, Stockholm School of Economics. [Downloadable!]
  4. Niosi, Jorge, 2003. "Alliances are not enough explaining rapid growth in biotechnology firms," Research Policy, Elsevier, vol. 32(5), pages 737-750, May. [Downloadable!] (restricted)
  5. Günseli Baygan, 2003. "Venture Capital Policy Review: Norway," OECD Science, Technology and Industry Working Papers 2003/17, OECD, Directorate for Science, Technology and Industry. [Downloadable!]
Full references

Statistics
Access and download statistics

Did you know? IDEAS also indexes books.

This page was last updated on 2009-12-18.


This information is provided to you by IDEAS at the Department of Economics, College of Liberal Arts and Sciences, University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics.